SCHEMBL4904043

SCHEMBL4904043

COc1cncc2ccc(-c3nnc(N[C@@H](CN)Cc4ccccc4)s3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.41
CDK2 P24941 2/20 0.41
NOX1 Q9Y5S8 5/20 0.40
ROCK1 Q13464 3/20 0.40
ROCK2 O75116 2/20 0.40
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
IMPDH2 P12268 1/20 0.36
SGK1 O00141 1/20 0.35
NPC1 O15118 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PRKACA P17612 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4893225 0.99 AKT1 (0.40) AKT1CDK2NOX1ROCK1ROCK2
SCHEMBL14022914 0.88 PDE10A (0.36) AKT1CDK2NOX1KDM4EALDH1A1
SCHEMBL4898249 0.86 AKT1 (0.44) AKT1CDK2NOX1ROCK1ROCK2
SCHEMBL14022875 0.86 AKT1 (0.40) AKT1CDK2NOX1ROCK1SGK1
Hydrochloric Acid SCHEMBL4902235 0.85 AKT1 (0.44) AKT1CDK2NOX1ROCK1ROCK2
SCHEMBL4896070 0.82 ROCK2 (0.36) AKT1NOX1ROCK1ROCK2KDM4E
SCHEMBL4780577 0.81 AKT1 (0.53) AKT1CDK2NOX1ROCK1ROCK2
SCHEMBL4898277 0.81 AKT1 (0.53) AKT1CDK2NOX1ROCK1ROCK2
SCHEMBL4899252 0.81 AKT1 (0.53) AKT1CDK2NOX1ROCK1ROCK2
SCHEMBL4850255 0.77 ROCK1 (0.49) AKT1CDK2ROCK1ROCK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith JAK2, CHEK2, MTOR AKT1 26/4885CDK2 64/4885NOX1 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.